Market Research Logo

Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters - Medical Devices Pipeline Assessment, 2016

Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters - Medical Devices Pipeline Assessment, 2016

Summary

GlobalData's Medical Devices sector report, “Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters - Medical Devices Pipeline Assessment, 2016 provides an overview of Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date


1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Overview
3 Products under Development
3.1 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters - Pipeline Products by Stage of Development
3.2 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters - Pipeline Products by Territory
3.3 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters - Pipeline Products by Regulatory Path
3.4 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters - Pipeline Products by Estimated Approval Date
3.5 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters - Ongoing Clinical Trials
4 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters - Pipeline Products under Development by Companies
4.1 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Companies - Pipeline Products by Stage of Development
4.2 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters - Pipeline Products by Stage of Development
5 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Companies and Product Overview
5.1 Acrostak (Schweiz) AG Company Overview
5.1.1 Acrostak (Schweiz) AG Pipeline Products & Ongoing Clinical Trials Overview
5.2 Caliber Therapeutics Company Overview
5.2.1 Caliber Therapeutics Pipeline Products & Ongoing Clinical Trials Overview
5.3 Concept Medical Inc Company Overview
5.3.1 Concept Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.4 Lifetech Scientific (Shenzhen) Co., Ltd. Company Overview
5.4.1 Lifetech Scientific (Shenzhen) Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview
5.5 Micell Technologies, Inc. Company Overview
5.5.1 Micell Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.6 Sahajanand Medical Technologies Private Limited Company Overview
5.6.1 Sahajanand Medical Technologies Private Limited Pipeline Products & Ongoing Clinical Trials Overview
5.7 SurModics, Inc. Company Overview
5.7.1 SurModics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.8 The Spectranetics Corporation Company Overview
5.8.1 The Spectranetics Corporation Pipeline Products & Ongoing Clinical Trials Overview
5.9 Vascular Nanotransfer Technologies Company Overview
5.9.1 Vascular Nanotransfer Technologies Pipeline Products & Ongoing Clinical Trials Overview
6 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters- Recent Developments
6.1 May 19, 2016: EuroPCR 2016: Pantera Lux Drug-Coated Balloon Proves Non-Inferior to Drug-Eluting Stent
6.2 Jan 05, 2016: QT Vascular Announces Clinical Outcomes of Its Chocolate Heart Drug Coated Coronary Balloon
6.3 Oct 15, 2015: ISAR-DESIRE 4 Is First Trial to Examine Role of Lesion Preparation before Drug-Coated Balloon Therapy in Restenosis
6.4 Aug 18, 2015: Elixir Medical Receives 2015 Innovator of the Year Award from EK-UNICO
6.5 Jun 25, 2015: The New England Journal of Medicine publishes LEVANT 2 results for the Lutonix Drug Coated Balloon, showing superior efficacy compared to standard PTA
6.6 Jun 09, 2015: CMS Further Improves Reimbursement for Lutonix DCB for Outpatient Use
7 Appendix
7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer
1.1 List of Tables
Table 1: Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters - Pipeline Products by Stage of Development
Table 2: Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters - Pipeline Products by Territory
Table 3: Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters - Pipeline Products by Regulatory Path
Table 4: Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters - Pipeline Products by Estimated Approval Date
Table 5: Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters - Ongoing Clinical Trials
Table 6: Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Companies - Pipeline Products by Stage of Development
Table 7: Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters - Pipeline Products by Stage of Development
Table 8: Acrostak (Schweiz) AG Pipeline Products & Ongoing Clinical Trials Overview
Table 9: Genie Catheter - Product Status
Table 10: Genie Catheter - Product Description
Table 11: Caliber Therapeutics Pipeline Products & Ongoing Clinical Trials Overview
Table 12: Drug Delivery Balloon Catheter - Product Status
Table 13: Drug Delivery Balloon Catheter - Product Description
Table 14: TADD Device - Product Status
Table 15: TADD Device - Product Description
Table 16: Concept Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 17: Magic Touch - Product Status
Table 18: Magic Touch - Product Description
Table 19: Concept Medical Inc - Ongoing Clinical Trials Overview
Table 20: Magic Touch - Assessment of the Novel MagicTouch Sirolimus Drug Coated Balloon Catheter for the Treatment of Coronary Lesions
Table 21: Lifetech Scientific (Shenzhen) Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview
Table 22: PTCA Drug Eluting Balloon - Product Status
Table 23: PTCA Drug Eluting Balloon - Product Description
Table 24: Micell Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 25: Drug-Coated Balloon - Product Status
Table 26: Drug-Coated Balloon - Product Description
Table 27: Sahajanand Medical Technologies Private Limited Pipeline Products & Ongoing Clinical Trials Overview
Table 28: Identity Balloon Catheter - Product Status
Table 29: Identity Balloon Catheter - Product Description
Table 30: SurModics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 31: SurVeil Drug Coated Balloon - Coronary - Product Status
Table 32: SurVeil Drug Coated Balloon - Coronary - Product Description
Table 33: The Spectranetics Corporation Pipeline Products & Ongoing Clinical Trials Overview
Table 34: AngioSculptX - Product Status
Table 35: AngioSculptX - Product Description
Table 36: Vascular Nanotransfer Technologies Pipeline Products & Ongoing Clinical Trials Overview
Table 37: Mitomycin-Based DCB - Coronary - Product Status
Table 38: Mitomycin-Based DCB - Coronary - Product Description
Table 39: Paclitaxel-Based Drug Coated Balloon - Coronary - Product Status
Table 40: Paclitaxel-Based Drug Coated Balloon - Coronary - Product Description
Table 41: Glossary
1.2 List of Figures
Figure 1: Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters - Pipeline Products by Stage of Development
Figure 2: Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters - Pipeline Products by Territory
Figure 3: Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters - Pipeline Products by Regulatory Path
Figure 4: Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters - Pipeline Products by Estimated Approval Date
Figure 5: Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters - Ongoing Clinical Trials

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report